Welcome to The QUAD – the home of Quality Use of Medicines (QUM) in Chronic Airways Disease (CAD) for healthcare professionals. The Lung Learning Partnership has worked with national key opinion leaders to design and deliver a program for healthcare professionals.
These education packages have been co-designed to meaningfully reflect priority QUM-related issues for people with CAD and promote patient empowerment as key to optimal management. Our evidence-based education packages provide support for the primary care workforce in delivering best-practice care at critical points in the patient journey.
This education package you are selecting to enrol in is being independently evaluated by a research team from the University of Wollongong (UOW).
The UOW research team is inviting you to participate in an interview, to contribute to the evaluation, before you engage in any of the education packages.
For details of UOW evaluation, please go to this link: https://redcap.link/LlpEvaluationBaseline
Our education packages all include multi-modal education and behaviour change activities that support healthcare professionals to deliver evidence-based care.
The Quality Use of Medicines in Chronic Airways Disease Program is funded by the Australian Government Department of Health and Aged Care. This is an initiative by the Lung Foundation Australia, Thoracic Society of Australia and New Zealand and Asthma Australia.